Table 1.
Clinical Characteristics of Patients
| Items | Total Patients (N=286) | VL Patients (n=49) | Non-VL Patients (n=237) | P value |
|---|---|---|---|---|
| Age, No. (%) | 0.681 | |||
| <60 years | 211 (73.8) | 35 (71.4) | 176 (74.3) | |
| ≥60 years | 75 (26.2) | 14 (28.6) | 61 (25.7) | |
| Gender, No. (%) | 0.709 | |||
| Male | 199 (69.6) | 33 (67.3) | 166 (70.0) | |
| Female | 87 (30.4) | 16 (32.7) | 71 (30.0) | |
| Etiology, No. (%) | 0.906 | |||
| Hepatitis B | 183 (64.0) | 33 (67.3) | 150 (63.3) | |
| Hepatitis C | 51 (17.8) | 9 (18.4) | 42 (17.7) | |
| Alcoholic cirrhosis | 31 (10.8) | 4 (8.2) | 27 (11.4) | |
| Alcohol/hepatitis | 4 (1.4) | 1 (2.0) | 3 (1.3) | |
| Others | 17 (6.0) | 2 (4.1) | 15 (6.3) | |
| Tumor number, No. (%) | 0.966 | |||
| Unifocal | 205 (71.7) | 35 (71.4) | 170 (71.7) | |
| Multifocal | 81 (28.3) | 14 (28.6) | 67 (28.3) | |
| Portal vein invasion, No. (%) | 0.151 | |||
| No | 205 (71.7) | 31 (63.3) | 174 (73.4) | |
| Yes | 81 (28.3) | 18 (36.7) | 63 (26.6) | |
| Child-Pugh stage, No. (%) | 0.662 | |||
| A | 173 (60.5) | 31 (63.3) | 142 (59.9) | |
| B | 113 (39.5) | 18 (36.7) | 95 (40.1) | |
| BCLC stage, No. (%) | 0.359 | |||
| A | 30 (10.5) | 5 (10.2) | 25 (10.5) | |
| B | 172 (60.1) | 33 (67.3) | 139 (58.7) | |
| C | 84 (29.4) | 11 (22.5) | 73 (30.8) | |
| Loading drugs, No. (%) | 0.819 | |||
| Doxorubicin | 156 (54.5) | 26 (53.1) | 130 (54.9) | |
| Arsenic trioxide | 130 (45.5) | 23 (46.9) | 107 (45.1) |
Note: Comparison between the two groups (VL group and non-VL group) was determined by Chi-square test or Wilcoxon rank sum test.
Abbreviations: VL, vascular lake; BCLC, Barcelona Clinic Liver Cancer.